These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29434411)

  • 1. Metabolic Footprints and Molecular Subtypes in Breast Cancer.
    Cappelletti V; Iorio E; Miodini P; Silvestri M; Dugo M; Daidone MG
    Dis Markers; 2017; 2017():7687851. PubMed ID: 29434411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
    Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
    Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer.
    Trilla-Fuertes L; Gámez-Pozo A; López-Camacho E; Prado-Vázquez G; Zapater-Moros A; López-Vacas R; Arevalillo JM; Díaz-Almirón M; Navarro H; Maín P; Espinosa E; Zamora P; Fresno Vara JÁ
    BMC Cancer; 2020 Apr; 20(1):307. PubMed ID: 32293335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics and transcriptomics profiles reveal the dysregulation of the tricarboxylic acid cycle and related mechanisms in prostate cancer.
    Shao Y; Ye G; Ren S; Piao HL; Zhao X; Lu X; Wang F; Ma W; Li J; Yin P; Xia T; Xu C; Yu JJ; Sun Y; Xu G
    Int J Cancer; 2018 Jul; 143(2):396-407. PubMed ID: 29441565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid metabolism in breast cancer subtypes.
    Monaco ME
    Oncotarget; 2017 Apr; 8(17):29487-29500. PubMed ID: 28412757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive profiling of biological processes reveals two major prognostic subtypes in breast cancer.
    Chen F; Gao S; Wang F; Ma J; Zhang M; Lv M; Zhou Q; Fu Z; Lu C; Yin H
    Tumour Biol; 2016 Mar; 37(3):3365-70. PubMed ID: 26446459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer.
    Yamashita Y; Nishiumi S; Kono S; Takao S; Azuma T; Yoshida M
    BMC Cancer; 2017 Aug; 17(1):589. PubMed ID: 28851309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.
    Cejalvo JM; Martínez de Dueñas E; Galván P; García-Recio S; Burgués Gasión O; Paré L; Antolín S; Martinello R; Blancas I; Adamo B; Guerrero-Zotano Á; Muñoz M; Nucíforo P; Vidal M; Pérez RM; Chacón López-Muniz JI; Caballero R; Peg V; Carrasco E; Rojo F; Perou CM; Cortés J; Adamo V; Albanell J; Gomis RR; Lluch A; Prat A
    Cancer Res; 2017 May; 77(9):2213-2221. PubMed ID: 28249905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations.
    El Ansari R; McIntyre A; Craze ML; Ellis IO; Rakha EA; Green AR
    Histopathology; 2018 Jan; 72(2):183-190. PubMed ID: 28771772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification.
    Nam H; Chung BC; Kim Y; Lee K; Lee D
    Bioinformatics; 2009 Dec; 25(23):3151-7. PubMed ID: 19783829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.
    Li Y; Li S; Chen J; Shao T; Jiang C; Wang Y; Chen H; Xu J; Li X
    Hum Mol Genet; 2014 Oct; 23(20):5378-93. PubMed ID: 24871326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells.
    Baumann J; Wong J; Sun Y; Conklin DS
    BMC Cancer; 2016 Jul; 16():551. PubMed ID: 27464732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue.
    Sun X; Stewart DA; Sandhu R; Kirk EL; Pathmasiri WW; McRitchie SL; Clark RF; Troester MA; Sumner SJ
    PLoS One; 2018; 13(4):e0193792. PubMed ID: 29668675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Integrative Approach for Identifying Network Biomarkers of Breast Cancer Subtypes Using Genomic, Interactomic, and Transcriptomic Data.
    Firoozbakht F; Rezaeian I; D'agnillo M; Porter L; Rueda L; Ngom A
    J Comput Biol; 2017 Aug; 24(8):756-766. PubMed ID: 28650678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritizing breast cancer subtype related miRNAs using miRNA-mRNA dysregulated relationships extracted from their dual expression profiling.
    Hua L; Zhou P; Li L; Liu H; Yang Z
    J Theor Biol; 2013 Aug; 331():1-11. PubMed ID: 23619378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple-negative breast cancer: current state of the art.
    Rastelli F; Biancanelli S; Falzetta A; Martignetti A; Casi C; Bascioni R; Giustini L; Crispino S
    Tumori; 2010; 96(6):875-88. PubMed ID: 21388048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.
    Wu YM; Hu W; Wang Y; Wang N; Gao L; Chen ZZ; Zheng WQ
    Breast Cancer Res Treat; 2013 Aug; 141(1):23-32. PubMed ID: 23933801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New omics information for clinical trial utility in the primary setting.
    Damia G; Broggini M; Marsoni S; Venturini S; Generali D
    J Natl Cancer Inst Monogr; 2011; 2011(43):128-33. PubMed ID: 22043059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic characterization of triple negative breast cancer.
    Cao MD; Lamichhane S; Lundgren S; Bofin A; Fjøsne H; Giskeødegård GF; Bathen TF
    BMC Cancer; 2014 Dec; 14():941. PubMed ID: 25495193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.